Loading
Active vitamin D (calcitriol, paricalcitol) used to control secondary hyperparathyroidism in CKD.
CKD lowers activation of vitamin D, driving secondary hyperparathyroidism. Active vitamin D analogs suppress PTH and help manage CKD-MBD, but raise calcium and phosphorus — monitoring is required. Cholecalciferol (plain D3) is used for deficiency at earlier stages. Dosing is guided by PTH, calcium, and phosphorus trends.
Overactive parathyroid glands caused by kidney failure — driven by low vitamin D, high phosphate, and low calcium — damaging bones and vessels if untreated.
Bone disease caused by chronic kidney disease — abnormal bone turnover from calcium, phosphate, vitamin D, and PTH disturbances.
Blood calcium above the normal range - in CKD usually from over-suppressed PTH, excess calcium binders, or tertiary hyperparathyroidism.
Blood phosphate above ~5.5 mg/dL - a CKD mineral-bone disorder driver that accelerates vascular calcification and bone disease.
Advertisement
ZuvFlo is ready to integrate with your facility to streamline operations, automate compliance, and deliver better patient care.
No credit card required • Setup in under 2 hours • Cancel anytime
Advertisement
This content is a general reference, not medical advice, a diagnosis, or a treatment plan. Do not change your diet, fluids, medicines, or dialysis plan without your nephrologist or renal dietitian. Individual recommendations depend on your labs, medications, conditions, and care plan.